F
Faculdade de Medicina de Botucatu | Unesp
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Baricitinib
Hydroxychloroquine
Remifentanil
Azithromycin
LY3009104
Sufentanil
S42909
JNJ-53718678
Mirikizumab
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 11 total trials
The reason for this study is to see if the study drug baricitinib is safe and effective in participants from 1 year to less than 18 years old with sy...
Enrolling
Systemic Juvenile Idiopathic Arthritis
Drug: Baricitinib
Drug: Tocilizumab
The reason for this study is to see if the study drug baricitinib is safe and effective in the treatment of JIA in participants ages 1 to 17. This st...
Enrolling
Juvenile Idiopathic Arthritis
Drug: Baricitinib
Trial sponsors
U
I
H
U
U
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems